A Next-Generation Therapyfor Obesity Management

Tirzide (Tirzepatide) is a once-weekly injectable (prescription) medicine that may help adults to reduce excess body weight and maintain weight reduction long term in adults with obesity or adults with overweight in the presence of at least one weight-related comorbid condition.

SHOP NOW

Treats 4 Types of Disease withTirzepatide(Tirzide)

  • Overweight & Obesity

    Reduce weight upto 22%

  • Type 2 Diabetes Mellitus

    Superior HbA1c reduction up to less than 7%

  • Sleep Apnea

    Improve Obstructive Sleep Apnea (OSA) in obese patients

  • Cardiovascular Events

    Decreases the risk of cardiovascular events

    Tirzepatide(Tirzide) works with yourmetabolic hormone

    See how Tirzepatide can help peoplewith overweight and obesity

    • 48 lbs weight reduction

      Tirzepatide decreases upto 48 lbs in non-diabetes patient in 72 weeks trial

    • 48 lbs weight reduction

      Tirzepatide decreases upto 48 lbs in non-diabetes patient in 72 weeks trial

    • Reduce upto HbA1C <7%

      Tirzepatide reduces less than 7% of HbA1C in the 40 week clinical trial in patient taking with or without other diabetes medication

    • Neutralize the risk of cardiovascular event

      Tirzepatide decreases upto 48 lbs in non-diabetes patient in 72 weeks trial

      Built for International Healthcare Markets

      • Medical Governance

        Content aligned for healthcare professionals with indication boundaries and safety-forward communication.

      • Quality-First Positioning

        Brand narrative centered on manufacturing quality, traceability, and responsible therapeutic use.

      • Cross-Region Accessibility

        Multilingual interface support and structured pathways for verification, education, and contact.